Cleo Diagnostics

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.

Details

Level 2, 480 Collins Street MELBOURNE VIC 3000
+61 3 9614 0600
cleodx.com
Established 2023

Lists and Charts

Share price

Cleo Diagnostics
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 01/12/25

Rank Company 1 Yr 5 Yr
294th Blue Star Helium 85.71% -26.35%
295th West African Resources 85.48% 25.99%
296th Cleo Diagnostics 85.29% 0%
297th Carnegie Clean Energy 85.19% -2.24%
298th SSH Group 84.77% 0%
View Full List
1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

      Company Activity

      		 NEW ROLE: Lucinda Nolan, Non-Executive Director 17 Jul 2024
      		NEW ROLE: Richard Allman, Chief Executive Officer, Executive Director 17 Jul 2024
      		NEW ROLE: Andrew Stephens, Chief Scientific Officer, Executive Director 17 Jul 2024

    Related Information

    Access to our data for Cleo Diagnostics is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Cleo Diagnostics is included in 1 list - Public Companies - non WA.

    For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

    Subscribe today

    X